Literature DB >> 20127389

Aspergillus keratitis in vernal shield ulcer--a case report and review.

Vandana Jain1, Kanupriya Mhatre, Akshay G Nair, Debraj Shome, Sundaram Natarajan.   

Abstract

An unusual case of vernal shield ulcer with superadded fungal keratitis caused by Aspergillus fumigates is reported. A 26-year-old man, a known case of vernal keratoconjunctivitis (VKC) presented with the complaint of diminution of vision in the right eye. Patient was on topical steroids and anti-allergic treatment for the past two months. In the right eye, a shield ulcer with an elevated plaque was seen. Scrapings from the right cornea revealed fungal filaments on a wet KOH mount and culture revealed growth of Aspergillus fumigatus. The patient was diagnosed as VKC with shield ulcer with secondary fungal keratitis. The patient was treated with topical cyclosporine, topical moxifloxacin, topical natamycin, and topical amphotericin eye drops. The patient responded well and finally recovered to a best spectacle-corrected visual acuity of 20/20 at the end of nine months. The chronic ocular surface changes and induced inflammation in VKC, and the instillation of topical steroids for therapy, may create an environmental milieu favorable for fungal keratitis. Microbiological evaluation should be considered, even in cases of suspected sterile keratitis, to prevent possible worsening of an associated infective corneal condition. This warrants patient education, periodic reviews and a very cautious approach to indiscriminate use of topical corticosteroids in cases of VKC with shield ulcer. In the event of any secondary fungal infection, use of steroid sparing topical agent, for example cyclosporine may be considered.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20127389     DOI: 10.1007/s10792-010-9349-0

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  13 in total

1.  Penicillium keratitis in vernal Keratoconjunctivitis.

Authors:  Ritu Arora; Seema Gupta; Usha K Raina; Dinesh K Mehta; Mukesh Taneja
Journal:  Indian J Ophthalmol       Date:  2002-09       Impact factor: 1.848

2.  Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup.

Authors:  S Bonini; S Bonini; A Lambiase; S Marchi; P Pasqualetti; O Zuccaro; P Rama; L Magrini; T Juhas; M G Bucci
Journal:  Ophthalmology       Date:  2000-06       Impact factor: 12.079

3.  Ocular atopy and mycotic keratitis.

Authors:  R B Vajpayee; S K Gupta; U Bareja; K Kishore
Journal:  Ann Ophthalmol       Date:  1990-10

4.  Effects of methylprednisolone and cyclosporine A on fungal growth in vitro.

Authors:  N P Bell; C L Karp; E C Alfonso; J Schiffman; D Miller
Journal:  Cornea       Date:  1999-05       Impact factor: 2.651

5.  Topical cyclosporin A in the management of therapeutic keratoplasty for mycotic keratitis.

Authors:  Henry D Perry; Sima J Doshi; Eric D Donnenfeld; Grace S Bai
Journal:  Cornea       Date:  2002-03       Impact factor: 2.651

6.  Mycotic keratitis in non-steroid exposed vernal keratoconjunctivitis.

Authors:  A Gupta; A Sharma; K Mohan; A Gupta
Journal:  Acta Ophthalmol Scand       Date:  1999-04

7.  Case series of 406 vernal keratoconjunctivitis patients: a demographic and epidemiological study.

Authors:  Andrea Leonardi; Francesca Busca; Laura Motterle; Fabiano Cavarzeran; Iva A Fregona; Mario Plebani; Antonio G Secchi
Journal:  Acta Ophthalmol Scand       Date:  2006-06

8.  Secondary bacterial keratitis associated with shield ulcer caused by vernal conjunctivitis.

Authors:  Sansal Gedik; Yonca A Akova; Sirel Gür
Journal:  Cornea       Date:  2006-09       Impact factor: 2.651

Review 9.  Classification of ocular allergy.

Authors:  Marcus G Hodges; Andrea M Keane-Myers
Journal:  Curr Opin Allergy Clin Immunol       Date:  2007-10

10.  The changing spectrum of fungal keratitis in south Florida.

Authors:  R H Rosa; D Miller; E C Alfonso
Journal:  Ophthalmology       Date:  1994-06       Impact factor: 12.079

View more
  1 in total

1.  Vernal shield ulcers treated with frequently installed topical cyclosporine 0.05% eyedrops.

Authors:  Tim Westland; Eliza K Patryn; Carla P Nieuwendaal; Ivanka J E van der Meulen; Maarten P Mourits; Ruth Lapid-Gortzak
Journal:  Int Ophthalmol       Date:  2017-01-24       Impact factor: 2.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.